Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/1989
03/29/1989EP0309050A1 Human insulin-like growth factor analogs with reduced binding to serum carrier proteins and their production in yeast
03/29/1989EP0308936A2 Antibody heteroconjugates for the killing of HIV-infected cells
03/29/1989EP0308757A1 Multidentate chelators based on the 8-hydroxyquinoline unit
03/29/1989EP0308724A2 Use of a immunistimulating biologic to manufacture a medicament to treat human immunodeficiency virus
03/29/1989EP0308717A2 Method of treating viral encephalitis
03/29/1989EP0308716A2 Modified plasminogen activators
03/29/1989EP0308475A1 Adjuvant for certain antimitotic chemicals, obtained from vibrio cholerae
03/29/1989EP0308424A1 A novel protein, neuroleukin
03/29/1989EP0152483B1 Process for producing peptide
03/29/1989CN1032014A Ring groth hormone releasing factor (grf), analogue and its process
03/28/1989US4816567 Immunology, vectors, dna
03/28/1989US4816566 Viricides
03/28/1989US4816565 Interleukin 2 receptor and a method for production thereof
03/28/1989US4816564 Method for producing hepatitis B virus proteins in yeast
03/28/1989US4816563 Process for obtaining transfer factor from colostrum, transfer factor so obtained and use thereof
03/28/1989US4816561 Biologically active polypeptides
03/28/1989US4816559 Biologically active peptides TAN-866
03/28/1989US4816443 Piptides having ANF activity
03/28/1989US4816441 Anticarcinogenic agents, viricides
03/28/1989US4816440 Interleukins, sodium laurate
03/28/1989US4816438 Insulin-selective somatostatin analogs
03/28/1989US4816437 Calcium deficiency, glycoproteins
03/28/1989US4816436 Anti-arthritic use of interleukin-1 proteins
03/28/1989US4816405 Vectors for transformation by ascomycetes
03/28/1989US4816397 Genetic engineering
03/28/1989US4816396 Genetic engineering
03/28/1989US4816389 Probe for DNA and a process for the detection of "shigellae" and entero-invasive strains of Escherichia coli
03/28/1989US4816388 Genetic engineering, dna, endonuclease assay
03/28/1989CA1251899A1 Cyanogen bromide cleavage of peptides
03/28/1989CA1251747A1 Monoclonal antibody to candida albicans cytoplasmic antigens and methods of preparing same
03/23/1989WO1989002472A1 Regulation of expression of gm-csf gene
03/23/1989WO1989002471A1 RECOMBINANT DNA CONSTRUCTS CONTAINING AN r3 PROMOTER
03/23/1989WO1989002468A1 Transduced fibroblasts and uses therefor
03/23/1989WO1989002467A1 Artificial gene coding for authentic human serum albumin, use thereof, and method of producing the same
03/23/1989WO1989002463A1 Synthetic yeast leader peptides
03/23/1989WO1989002462A1 Recombinant plasmids for producing human adrenocorticotropic hormone (acth)
03/23/1989WO1989002461A1 Process for producing peptides by specific cleavage of fusion proteins with collagenases obtained by genetic engineering
03/23/1989WO1989002460A1 cDNA ENCODING PEPTIDYL-GLYCINE ALPHA-AMIDATING MONOOXYGENASE (PAM)
03/23/1989WO1989002440A2 Y-specific dna hybridization probes and uses therefor
03/23/1989WO1989002437A1 Pathogenesis-related proteins in plants
03/23/1989WO1989002277A2 Prophylaxis and therapy of acquired immunodeficiency syndrome
03/23/1989WO1989001973A3 Recombinant pox virus for immunization against tumor-associated antigens
03/23/1989EP0222003A4 MOLECULAR CLONING OF cDNA FOR HUMAN FACTOR VIIIR (VON WILLEBRAND FACTOR).
03/22/1989EP0308381A1 Artificial gene coding for authentic human serum albumin, use thereof, and method of producing the same
03/22/1989EP0308378A2 Tumor necrosis factor (TNF)inhibitory protein and its purification
03/22/1989EP0308341A1 Process for the industrial synthesis of perindopril and for its principal synthesis intermediates
03/22/1989EP0308336A2 Process for the production of human pro-apolipoprotein A-I-like proteins
03/22/1989EP0308265A2 Methods and compositions relating to regression-associated antigens
03/22/1989EP0308239A2 Method for reducing bacterial endotoxin contamination in solutions of macromolecules
03/22/1989EP0308235A2 Attachment of compounds to polymeric particles using carbamoylonium compounds
03/22/1989EP0308220A1 Recombinant avipoxvirus
03/22/1989EP0308208A1 Modified antibody conjugates with enhanced clearance
03/22/1989EP0308199A1 Bacillus thuringiensis toxin
03/22/1989EP0308067A2 Alpha-amidating enzyme compositions and processes for their production and use
03/22/1989EP0307939A1 Advanced glycosylation endproducts and associated methods
03/22/1989EP0307872A2 Esters of amino-acids, process for their preparation, medicaments containing them and their use
03/22/1989EP0307860A2 Cyclic GRF-analogs
03/22/1989EP0307841A1 Pathogenesis-related proteins in plants
03/22/1989EP0307774A2 Process for purifying plasminogen activator
03/22/1989EP0307754A2 Method for obtaining a papain-free antibody fragment preparation
03/22/1989EP0307730A2 Expression of mutarotase
03/22/1989EP0307662A2 Enkephalin analogs
03/22/1989EP0307592A2 Analogues of the pancreatic bovine trypsin inhibitor, their production and use
03/22/1989EP0307553A2 Modified splenopentines, their process of preparation and their use
03/22/1989EP0307513A2 Pulmonary hydrophobic surfactant-associated proteins
03/22/1989EP0307480A1 Process for preparing antibody complex
03/21/1989US4814485 4-aminobutanoic acid derivatives, process of preparation and use thereof
03/21/1989US4814435 Method of producing a factor VIII (AHF) containing fraction
03/21/1989US4814434 Inducer of T-suppressor cells
03/21/1989US4814433 Method for obtaining a papain-free antibody fragment preparation
03/21/1989US4814432 Inhibitor of ribonucleotide reductase
03/21/1989US4814271 Method for detecting esterolytic and proteolytic enzymes
03/21/1989CA1251401A1 Method for preparation of herpes simplex virus subunit vaccine
03/21/1989CA1251386C Selection using opine synthase genes
03/16/1989DE3825186A1 Lectin-containing compositions which can be administered orally for treating metastases
03/15/1989EP0307285A1 Recombinant eukaryotic cells producing interleukin-2, method and vectors for obtaining them and method for obtaining interleukin-2
03/15/1989EP0307248A2 Method for increasing the expression of polypeptides in recombinant cell culture
03/15/1989EP0307247A2 A method for culturing recombinant cells
03/15/1989EP0307149A2 Solid phase immunoassay for an antibody and biological constructions for use therein
03/15/1989EP0307002A1 Method for producing an antithrombin III concentrate
03/15/1989EP0306985A2 Bacteriorhodopsin modifications and methods for their preparation
03/15/1989EP0306968A2 Process for producing recombinant human factor VIII:C
03/15/1989EP0306943A2 Immunconjugates joined by thioether bonds having reduced toxicity and improved selectivity
03/15/1989EP0306870A2 Gamma-interferon derivatives, process for their manufacture, vectors and medicines obtained therefrom
03/15/1989EP0306680A2 Monoclonal antibodies to anti-thrombin binding substance, and their uses
03/15/1989EP0306673A1 A method for the preparation of human growth hormone
03/15/1989EP0306610A1 Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase
03/15/1989EP0306524A1 Antigenic determinants recognized by antibodies obtained using a pathogenic agent or a derivative thereof that presents a restricted set of antigens
03/15/1989CN1031717A Dna fraginents coding for antigens specific to non-a non-b hepatitis expression vectors containing said dna fragments transformants and process for producing said antigens
03/14/1989US4812559 Vaccine against varicella-zoster virus
03/14/1989US4812556 Immunoassay for aids
03/14/1989US4812555 Peptides possessing renin inhibitory activity
03/14/1989US4812554 Somatostatin peptide conjugate
03/14/1989US4812441 Hypocholesterolemically active protein derived from streptococcus
03/14/1989US4812409 Hydrolyzable fluorescent substrates and analytical determinations using same
03/14/1989US4812393 Analytical determination of microorganisms
03/14/1989CA1251153A1 Preparation of peptides with c-terminal proline amide
03/14/1989CA1251134A1 Biologically active substance with hormonal properties, process for its production and application of histones for medical purposes
03/09/1989WO1989002077A1 Preparation containing high molecular staphylococcal protein; antibody preparation directed against the protein; and the use of the preparations
03/09/1989WO1989001976A1 Recombinant dna-derived bordetella toxin subunit analogs
1 ... 2822 2823 2824 2825 2826 2827 2828 2829 2830 2831 2832 2833 2834 2835 2836 2837 2838 2839 2840 2841 2842 ... 2916